Literature DB >> 12414870

Abdominal obesity, muscle composition, and insulin resistance in premenopausal women.

Robert Ross1, Jennifer Freeman, Robert Hudson, Ian Janssen.   

Abstract

The independent relationships between visceral and abdominal sc adipose tissue (AT) depots, muscle composition, and insulin sensitivity were examined in 40 abdominally obese, premenopausal women. Measurements included glucose disposal by euglycemic clamp, muscle composition by computed tomography, abdominal and nonabdominal (e.g. leg) AT by magnetic resonance imaging and cardiovascular fitness. Glucose disposal rates were negatively related to visceral AT mass (r = -0.42, P < 0.01). These observations remained significant (P < 0.01) after control for nonabdominal and abdominal sc AT, muscle attenuation, and peak oxygen uptake. Total, abdominal, or leg sc AT or muscle attenuation was not significantly (P > 0.10) related to glucose disposal. Subdivision of abdominal sc AT into anterior and posterior depots did not alter the observed relationships. Further analysis matched two groups of women for abdominal sc AT but with low and high visceral AT. Women with high visceral AT had lower glucose disposal rates compared with those with low visceral AT (P < 0.05). A similar analysis performed on two groups of women matched for visceral AT but high and low abdominal sc AT revealed no statistically different values for insulin sensitivity (P > 0.10). In conclusion, visceral AT alone is a strong correlate of insulin resistance independent of nonabdominal, abdominal sc AT, muscle composition, and cardiovascular fitness. Subdivision of abdominal sc AT did not provide additional insight into the relationship between abdominal obesity and metabolic risk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414870     DOI: 10.1210/jc.2002-020570

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  48 in total

Review 1.  Abdominal adipose tissue distribution and metabolic risk.

Authors:  Suzy Wong; Ian Janssen; Robert Ross
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.

Authors:  Sarah R Preis; Joseph M Massaro; Sander J Robins; Udo Hoffmann; Ramachandran S Vasan; Thomas Irlbeck; James B Meigs; Patrice Sutherland; Ralph B D'Agostino; Christopher J O'Donnell; Caroline S Fox
Journal:  Obesity (Silver Spring)       Date:  2010-03-25       Impact factor: 5.002

Review 3.  Molecular determinants of the cardiometabolic phenotype.

Authors:  Lisa de las Fuentes; Giovanni de Simone; Donna K Arnett; Víctor G Dávila-Román
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

4.  Abdominal fat deposits determined by magnetic resonance imaging in relation to leptin and vaspin levels as well as insulin resistance in the general adult population.

Authors:  F Genske; J-P Kühn; M Pietzner; G Homuth; W Rathmann; H J Grabe; H Völzke; H Wallaschofski; N Friedrich
Journal:  Int J Obes (Lond)       Date:  2017-08-14       Impact factor: 5.095

5.  Correlations of neck circumference with body composition and cardiometabolic risk factors in Arab women.

Authors:  Reem S Albassam; Kai Y Lei; Abdullah M Alnaami; Nasser M Al-Daghri
Journal:  Eat Weight Disord       Date:  2019-01-02       Impact factor: 4.652

6.  Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.

Authors:  Lucia Pacifico; Michele Di Martino; Caterina Anania; Gian Marco Andreoli; Mario Bezzi; Carlo Catalano; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

7.  Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal.

Authors:  Brian C Cooper; Cynthia K Sites; Peter R Casson; Michael J Toth
Journal:  Fertil Steril       Date:  2007-05       Impact factor: 7.329

8.  Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes.

Authors:  Susan Sam; Steven Haffner; Michael H Davidson; Ralph B D'Agostino; Steven Feinstein; George Kondos; Alfonso Perez; Theodore Mazzone
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 19.112

Review 9.  Abdominal obesity: the cholesterol of the 21st century?

Authors:  Jean-Pierre Després; Benoit J Arsenault; Mélanie Côté; Amélie Cartier; Isabelle Lemieux
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

Review 10.  Putative environmental-endocrine disruptors and obesity: a review.

Authors:  Mai A Elobeid; David B Allison
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-10       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.